Literature DB >> 16140226

Does Helicobacter pylori infection play a role in lung cancer?

Ferah Ece1, Nilgun F Hatabay, Nuray Erdal, Canan Gedik, Cengiz Guney, Ferda Aksoy.   

Abstract

BACKGROUND: Helicobacter pylori infection is a world-wide common disease and leads to many gastrointestinal and respiratory illnesses. It is suggested that one of these respiratory illnesses is lung cancer.
METHODS: Forty-three patients with non-small cell lung cancer and 28 control subjects have been included to this study. H. pylori status of the patients and controls was determined by immunoblot for the detection of IgG (RIDA Blot Helicobacter). All subjects were examined to evaluate the presence of VacA and CagA gene.
RESULTS: Seropositivity of anti H. pylori IgG was significantly higher in cancer patients than in control groups, 40 (93%) and 12 (42%), respectively (P<0.01). Although both VacA and CagA seropositivity was high in lung cancer patients, only VacA positivity was statistically significant when compared with control subjects, 35 (81%) and 11 (42%), respectively (P<0.05).
CONCLUSION: H. pylori infection may be associated with development of lung cancer.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16140226     DOI: 10.1016/j.rmed.2005.02.038

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  7 in total

Review 1.  Nutritional immunity: the impact of metals on lung immune cells and the airway microbiome during chronic respiratory disease.

Authors:  Claire Healy; Natalia Munoz-Wolf; Janné Strydom; Lynne Faherty; Niamh C Williams; Sarah Kenny; Seamas C Donnelly; Suzanne M Cloonan
Journal:  Respir Res       Date:  2021-04-29

Review 2.  Role of bacteria in oncogenesis.

Authors:  Alicia H Chang; Julie Parsonnet
Journal:  Clin Microbiol Rev       Date:  2010-10       Impact factor: 26.132

3.  Associations of lung cancer risk with biomarkers of Helicobacter pylori infection.

Authors:  Hyung-Suk Yoon; Xiao-Ou Shu; Hui Cai; Wei Zheng; Jie Wu; Wanqing Wen; Regina Courtney; Chris Shidal; Tim Waterboer; William J Blot; Qiuyin Cai
Journal:  Carcinogenesis       Date:  2022-06-27       Impact factor: 4.741

4.  H pylori seroprevalence in patients with lung cancer.

Authors:  Katayoon Najafizadeh; Sayeed Falah Tafti; Masoud Shiehmorteza; Masoud Saloor; Masoud Jamali
Journal:  World J Gastroenterol       Date:  2007-04-28       Impact factor: 5.742

5.  Association between Helicobacter pylori and mortality in the NHANES III study.

Authors:  Yu Chen; Stephanie Segers; Martin J Blaser
Journal:  Gut       Date:  2013-01-08       Impact factor: 23.059

6.  Helicobacter pylori seropositivity and risk of lung cancer.

Authors:  Jill Koshiol; Roberto Flores; Tram K Lam; Philip R Taylor; Stephanie J Weinstein; Jarmo Virtamo; Demetrius Albanes; Guillermo Perez-Perez; Neil E Caporaso; Martin J Blaser
Journal:  PLoS One       Date:  2012-02-24       Impact factor: 3.240

Review 7.  Helicobacter pylori Infection and Risk of Lung Cancer: A Meta-Analysis.

Authors:  Pulikonda Mounika
Journal:  Lung Cancer Int       Date:  2013-02-28
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.